Avoiding Transfusion in Head and N eek
暂无分享,去创建一个
[1] Y. Beguin. Prediction of response to optimize outcome of treatment with erythropoietin. , 1998, Seminars in oncology.
[2] D. Messinger,et al. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery , 1998, European journal of haematology.
[3] M. Helfaer,et al. Increased hematocrit and decreased transfusion requirements in children given erythropoietin before undergoing craniofacial surgery. , 1998, Journal of neurosurgery.
[4] P. Schlag,et al. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma , 1998, The British journal of surgery.
[5] M. Tsukuda,et al. Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia , 1998, Biotherapy.
[6] M. Mittelman. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin. , 1996, Israel journal of medical sciences.
[7] K. Messmer. Roundtable of Experts in Surgery Blood Management--consensus statement. , 1996, Infusionstherapie und Transfusionsmedizin.
[8] E. Genden,et al. Head and Neck Surgery in the Jehovah's Witness Patient , 1996, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[9] T. Price,et al. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial , 1996, Transfusion.
[10] Messmer,et al. Perioperative epoetin alfa reduces transfusion requirements in coronary artery bypass graft surgery. Discussion , 1996 .
[11] H. Samonigg,et al. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy , 1995, Cancer.
[12] M. Pogrel,et al. The use of erythropoietin in a patient having major oral and maxillofacial surgery and refusing blood transfusion. , 1995, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[13] L. Goodnough. Clinical application of recombinant erythropoietin in the perioperative period. , 1994, Hematology/oncology clinics of North America.
[14] A. Spallone,et al. Erythropoietin-augmented isovolemic hemodilution in skull-base surgery. Case report. , 1994, Journal of neurosurgery.
[15] R. Hilsinger,et al. Transfusion, Recurrence, and Infection in Head and Neck Cancer Surgery , 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[16] K. Takazawa,et al. Autologous blood transfusion with recombinant human erythropoietin in heart operations. , 1991, The Annals of thoracic surgery.
[17] G. Bakris,et al. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. , 1990, The New England journal of medicine.
[18] M. Weissler,et al. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.
[19] L. Goodnough,et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. , 1989, The New England journal of medicine.
[20] R. Thurer,et al. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. , 1989, JAMA.
[21] J. Adamson,et al. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.
[22] Waymack Jp,et al. Effect of blood transfusions on immune function: IV. Effect on tumor growth. , 1988 .
[23] J. Ward,et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. , 1988, The New England journal of medicine.
[24] J. Bove. Transfusion-associated hepatitis and AIDS. , 1987, The New England journal of medicine.